Mineralys Therapeutics, Inc.(MLYS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MLYS Mineralys Therapeutics, Inc.

Trading 06-08 14:24:37 EDT

22.79

-0.90

-3.82%

High23.80	Low22.30	Vol1.29M
Open23.76	D1 Closing23.69	Amplitude6.33%
Mkt Cap2.01B	Tradable Cap1.50B	Total Shares88.16M
T/O29.40M	T/O Rate1.95%	Tradable Shares66.03M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MLYS","market":"US","secType":"STK","nameCN":"Mineralys Therapeutics, Inc.","latestPrice":22.785,"timestamp":1780943076243,"preClose":23.69,"halted":0,"volume":1285538,"delay":0,"changeRate":-0.03820177289995783,"floatShares":66025800,"shares":88158500,"eps":-2.021721,"marketStatus":"Trading","change":-0.905,"latestTime":"06-08 14:24:37 EDT","open":23.76,"high":23.8,"low":22.3,"amount":29397150.771268,"amplitude":0.063318,"askPrice":22.8,"askSize":266,"bidPrice":22.77,"bidSize":362,"shortable":3,"etf":0,"ttmEps":-2.021721,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1780948800000},"marketStatusCode":2,"adr":0,"listingDate":1676005200000,"exchange":"NASDAQ","adjPreClose":23.69,"preHourTrading":{"tag":"盘前","latestPrice":23.7418,"preClose":23.69,"latestTime":"09:12 EDT","volume":3033,"amount":72401.634702,"timestamp":1780924378587,"change":0.0518,"changeRate":0.002187,"amplitude":0.042634},"postHourTrading":{"tag":"盘后","latestPrice":23.69,"preClose":23.69,"latestTime":"19:46 EDT","volume":92122,"amount":2182418.8195,"timestamp":1780703215053,"change":0,"changeRate":0,"amplitude":0.006754},"volumeRatio":0.495685,"impliedVol":0.8453,"impliedVolPercentile":0.4064},"requestUrl":"/m/hq/s/MLYS/tweets","defaultTab":"tweets","newsList":[{"id":"2640502841","title":"Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Mineralys Therapeutics, Inc. (MLYS) and ArriVent BioPharma, Inc. (AVBP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640502841","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640502841?lang=en_us&edition=fundamental","pubTime":"2026-06-04 21:00","pubTimestamp":1780578045,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Veeva Systems (VEEV), Mineralys Therapeutics, Inc. (...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-veeva-systems-veev-mineralys-therapeutics-inc-mlys-and-arrivent-biopharma-inc-avbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-veeva-systems-veev-mineralys-therapeutics-inc-mlys-and-arrivent-biopharma-inc-avbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","BK4585","LU0266013472.USD","BK4139","LU0058720904.USD","LU0289739699.SGD","BK4137","LABU","LU1989764664.SGD","BK4167","BK4504","BK4613","XBI","HCSG","AVBP","MLYS","LU0170899867.USD","BK4528","BK4588","XLV","BK4581","LU0029874061.USD","LU0128526141.USD","VEEV","LU1989764748.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640834811","title":"Mineralys Therapeutics falls -12.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640834811","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640834811?lang=en_us&edition=fundamental","pubTime":"2026-06-03 23:57","pubTimestamp":1780502226,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics (MLYS) is down -12.7%, or -$3.67 to $25.18. Published first on TheFly – the ultimate source for real-time, market-moving bre...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mineralys-therapeutics-falls-12-7-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mineralys-therapeutics-falls-12-7-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","BK4007","LENZ","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640018341","title":"Mineralys prices offering of 5.66M shares of common stock at $26.50","url":"https://stock-news.laohu8.com/highlight/detail?id=2640018341","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640018341?lang=en_us&edition=fundamental","pubTime":"2026-06-03 23:48","pubTimestamp":1780501691,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics (MLYS) announced the pricing of an underwritten offering of 5.66M shares of its common stock at a price of $26.50 per share....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mineralys-prices-offering-of-5-66m-shares-of-common-stock-at-26-50-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mineralys-prices-offering-of-5-66m-shares-of-common-stock-at-26-50-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640183562","title":"BUZZ-U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway","url":"https://stock-news.laohu8.com/highlight/detail?id=2640183562","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640183562?lang=en_us&edition=fundamental","pubTime":"2026-06-03 23:42","pubTimestamp":1780501359,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the RunwayWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call n","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nL6N42B103:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBN","GTLB","HIMS","KKR","TGTX","WDC","JZ","TPL","NOTV","AADX","FICO","MLYS","TISI","OLLI","FLR","HGV","OWL","GMEY","GME","NRXP","GPN","STLD","INCY","CETX","BX","FDX","XOS","MMED","TTI","SMR","CELC","TE","ARES","MX","MDT","USAR","WCT","AXSM","LUNR","SDOT","GRRR","REGN","YUM","LDOS","THO","CTMX","RJF","RENT","COCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640106902","title":"BUZZ-Mineralys Therapeutics falls after $150 mln stock deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2640106902","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640106902?lang=en_us&edition=fundamental","pubTime":"2026-06-03 21:14","pubTimestamp":1780492455,"startTime":"0","endTime":"0","summary":"BUZZ-Mineralys Therapeutics falls after $150 mln stock deal** Mineralys Therapeutics' MLYS.O shares down 8.5% premarket to $26.40 after $150 mln equity offering** Radnor, Pennsylvania-based MLYS early Weds says it sold ~5.66 mln shares at $26.50** Offering price represents 8.1% discount to stock's last close** BofA, Goldman Sachs and Evercore joint bookrunners** Co intends to use net proceeds to partially fund $200 mln upfront payment for the repurchase of the royalty obligation under its license agreement with Tanabe Pharma Corporation relating to MLYS's blood pressure drug, lorundrostat** MLYS also announced early Weds a $500 mln committed debt facility with funds managed by Pharmakon Advisors, LP** With ~82.5 mln shares outstanding, MLYS has about $2.4 bln market cap** Through Tues close, shares down ~21% YTD** 9 of 10 analysts rate the stock \"strong buy\" or \"buy\", 1 \"hold\"; median PT $51.50, per LSEG data","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nL6N42B0UD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU1280957306.USD","MLYS","LU0098860793.USD","LU1868836914.USD","LU1267930227.SGD","BK4552","LU2237438978.USD","IE00BBT3K403.USD","LU1069347547.HKD","LU0203345920.USD","LU2129689514.USD","LU0256863811.USD","LU0061475181.USD","LU2237443895.HKD","IE0002270589.USD","LU0321505439.SGD","LU0256863902.USD","BK4550","LU0980610538.SGD","LU0128525689.USD","EVR","LU0417517546.SGD","GSX","LU0251131958.USD","BAC","LU0345770308.USD","IE00BSNM7G36.USD","LU0320765489.SGD","IE00B7SZLL34.SGD","BK4534","LU1868836757.USD","LU0251142724.SGD","LU0640476718.USD","LU1880398554.USD","LU0048573561.USD","BK4559","LU2237443978.SGD","LU0211331839.USD","LU0477156953.USD","LU0971096721.USD","LU2471134879.HKD","LU0130103400.USD","LU0345770993.USD","LU0130518102.USD","LU0320765646.SGD","IE00BLSP4452.SGD","BK4516","LU1880398471.USD","IE0004091025.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640905384","title":"BRIEF-Mineralys Therapeutics Announces Pricing Of $150 Million Underwritten Offering Of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2640905384","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640905384?lang=en_us&edition=fundamental","pubTime":"2026-06-03 18:27","pubTimestamp":1780482470,"startTime":"0","endTime":"0","summary":"BRIEF-Mineralys Therapeutics Announces Pricing Of $150 Million Underwritten Offering Of Common StockJune 3 (Reuters) - Mineralys Therapeutics Inc MLYS.O:MINERALYS THERAPEUTICS ANNOUNCES PRICING OF $15","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA1XZ9NQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640890306","title":"Mineralys to repurchase future royalty payments in Tanabe license agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2640890306","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640890306?lang=en_us&edition=fundamental","pubTime":"2026-06-03 18:19","pubTimestamp":1780481993,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics (MLYS) announced the repurchase of all potential future royalty payments due to Tanabe Pharma Corporation related to lorundr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mineralys-to-repurchase-future-royalty-payments-in-tanabe-license-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mineralys-to-repurchase-future-royalty-payments-in-tanabe-license-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640039189","title":"Mineralys Therapeutics prices 5,660,378-share offering at $26.5 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2640039189","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640039189?lang=en_us&edition=fundamental","pubTime":"2026-06-03 18:05","pubTimestamp":1780481113,"startTime":"0","endTime":"0","summary":"Mineralys priced an underwritten follow-on offering of 5,660,378 common shares at USD 26.5 each.Gross proceeds expected at about USD 150 million; closing expected on or about June 4, 2026.Net proceeds earmarked to help fund a USD 200 million upfront payment to repurchase a royalty obligation tied to Tanabe Pharma.BofA Securities, Goldman Sachs, Evercore ISI named joint book-running managers.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL2D2R53:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1280957306.USD","BK4112","IE0004091025.USD","BK4127","LU0345770308.USD","LU1366192091.USD","LU1868837300.USD","BK4550","LU0170899867.USD","BK4553","LU0321505439.SGD","LU1201861249.SGD","LU0321505868.SGD","IE00BN0W2V16.EUR","LU0942090050.USD","LU1668664300.SGD","LU1880398554.USD","LU1506573853.SGD","LU0098860793.USD","LU0251142724.SGD","LU1496350502.SGD","BAC","LU1868837136.USD","LU0648000940.SGD","MLYS","LU0061475181.USD","LU0149725797.USD","LU0314106906.USD","LU1791807156.HKD","LU1267930227.SGD","LU1868836591.USD","GSX","NDAQ","LU1894683348.USD","BK4139","BK4207","IE00BBT3K403.USD","LU0234572021.USD","LU2237443549.SGD","LU2237443978.SGD","LU1496350171.SGD","EVR","LU0106831901.USD","IE00BKVL7J92.USD","IE00B19Z3B42.SGD","LU0211331839.USD","LU0648001328.SGD","LU0868494708.USD","LU1883839398.USD","IE00BLSP4239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640903514","title":"Mineralys inks up to $500 million senior secured term loan with Pharmakon Advisors","url":"https://stock-news.laohu8.com/highlight/detail?id=2640903514","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640903514?lang=en_us&edition=fundamental","pubTime":"2026-06-03 18:01","pubTimestamp":1780480865,"startTime":"0","endTime":"0","summary":"Mineralys entered an up to USD 500 million senior secured term loan facility with funds managed by Pharmakon Advisors.USD 100 million will fund at closing; remaining capacity available in four tranches subject to customary drawdown conditions.Five-year term matures in June 2031; interest set at SOFR with a 3.25% floor, plus a 5.5% margin.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL47w4q7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","IE00B3QW5Z07.USD","BK4585","IE00BN0W2W23.USD","NDAQ","IE00BGHQF748.EUR","SG9999014013.SGD","LU2210150020.SGD","BK4112","BK4588","BK4139","SG9999014021.USD","SG9999014039.USD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","LU0314104364.USD","MLYS","LU2095319765.USD","IE00BN0W2V16.EUR","IE00BKPKM429.USD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640903889","title":"Mineralys Therapeutics Announces Repurchase of Royalty Obligations in Tanabe License Agreement and Concurrent Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2640903889","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640903889?lang=en_us&edition=fundamental","pubTime":"2026-06-03 18:00","pubTimestamp":1780480800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA2JCGKB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640326903","title":"Mineralys Therapeutics - Secures $500 Mln Senior Secured Term Loan Facility From Pharmakon Advisors","url":"https://stock-news.laohu8.com/highlight/detail?id=2640326903","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640326903?lang=en_us&edition=fundamental","pubTime":"2026-06-03 18:00","pubTimestamp":1780480800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA2JCGKB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640033479","title":"Mineralys Therapeutics - Prices $150 Mln Common Stock Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2640033479","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640033479?lang=en_us&edition=fundamental","pubTime":"2026-06-03 18:00","pubTimestamp":1780480800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA2JCGKB:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640033239","title":"Mineralys Therapeutics - to Repurchase Lorundrostat Royalty Obligation for $200 Mln Upfront, up to $100 Mln in Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2640033239","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640033239?lang=en_us&edition=fundamental","pubTime":"2026-06-03 18:00","pubTimestamp":1780480800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA2JCGKB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640690049","title":"Buy Rating Reiterated on MLYS as Launch-HTN Data Highlight Lorundrostat’s Efficacy in Resistant CKD Hypertension; $54 Price Target Unchanged","url":"https://stock-news.laohu8.com/highlight/detail?id=2640690049","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640690049?lang=en_us&edition=fundamental","pubTime":"2026-06-02 02:45","pubTimestamp":1780339524,"startTime":"0","endTime":"0","summary":"In a report released today, Rami Katkhuda from LifeSci Capital maintained a Buy rating on Mineralys Therapeutics, Inc., with a price target of $54....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-on-mlys-as-launch-htn-data-highlight-lorundrostats-efficacy-in-resistant-ckd-hypertension-54-price-target-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-on-mlys-as-launch-htn-data-highlight-lorundrostats-efficacy-in-resistant-ckd-hypertension-54-price-target-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640501199","title":"Mineralys publishes ESH 2026 presentation on lorundrostat in CKD hypertension trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2640501199","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640501199?lang=en_us&edition=fundamental","pubTime":"2026-06-01 22:35","pubTimestamp":1780324510,"startTime":"0","endTime":"0","summary":"Mineralys published an ESH 2026 presentation on lorundrostat for hypertension in chronic kidney disease, reporting results from the LAUNCH-HTN trial.Primary endpoint: ambulatory office systolic blood pressure fell 16.9 mmHg at 6 weeks on lorundrostat 50 mg; placebo-adjusted decline was 9.1 mmHg.Predefined 12-week endpoint: ambulatory office systolic blood pressure fell 19.0 mmHg; placebo-adjusted decline was 11.6 mmHg.CKD subgroup analysis included 192 participants with baseline eGFR under 60 mL/min/1.73m or UACR at least 30 mg/g, out of 800 with baseline renal data.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief on May 30, 2026, and is solely r","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL3LP8vt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640953797","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2640953797","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640953797?lang=en_us&edition=fundamental","pubTime":"2026-06-01 18:40","pubTimestamp":1780310417,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Mineralys Therapeutics, Inc. (MLYS), Iovance Biother...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-196?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-196?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640986644","title":"Mineralys Therapeutics presents new data for lorundrostat","url":"https://stock-news.laohu8.com/highlight/detail?id=2640986644","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640986644?lang=en_us&edition=fundamental","pubTime":"2026-06-01 05:05","pubTimestamp":1780261504,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics (MLYS) presented new clinical data for lorundrostat at the 35th European Meeting on Hypertension and Cardiovascular Protecti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mineralys-therapeutics-presents-new-data-for-lorundrostat-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mineralys-therapeutics-presents-new-data-for-lorundrostat-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","EPV","LENZ","MLYS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639360972","title":"BRIEF-Mineralys Therapeutics Presents New Data From The Phase 3 Launch-Htn Trial Of Lorundrostat","url":"https://stock-news.laohu8.com/highlight/detail?id=2639360972","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639360972?lang=en_us&edition=fundamental","pubTime":"2026-05-30 23:15","pubTimestamp":1780154139,"startTime":"0","endTime":"0","summary":"BRIEF-Mineralys Therapeutics Presents New Data From The Phase 3 Launch-Htn Trial Of Lorundrostat May 30 (Reuters) - Mineralys Therapeutics Inc MLYS.O:MINERALYS THERAPEUTICS PRESENTS NEW DATA FROM THE ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nTUA7YXNFR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639717609","title":"Mineralys Therapeutics Presents New Data From the Phase 3 Launch-Htn Trial of Lorundrostat in Participants With Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)","url":"https://stock-news.laohu8.com/highlight/detail?id=2639717609","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639717609?lang=en_us&edition=fundamental","pubTime":"2026-05-30 23:15","pubTimestamp":1780154100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nTUA7YXNFR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639609748","title":"Mineralys Therapeutics: Lorundrostat Showed Significant Blood Pressure Reductions in Ckd Patients in Phase 3 Launch-Htn Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2639609748","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639609748?lang=en_us&edition=fundamental","pubTime":"2026-05-30 23:15","pubTimestamp":1780154100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nP8N3Z60BO:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mineralystx.com;www.ir.mineralystx.com","stockEarnings":[{"period":"1week","weight":-0.2479},{"period":"1month","weight":-0.2135},{"period":"3month","weight":-0.1091},{"period":"6month","weight":-0.3847},{"period":"1year","weight":0.5166},{"period":"ytd","weight":-0.3472}],"compareEarnings":[{"period":"1week","weight":-0.025},{"period":"1month","weight":0.0051},{"period":"3month","weight":0.0969},{"period":"6month","weight":0.0756},{"period":"1year","weight":0.2437},{"period":"ytd","weight":0.0816}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.014493},{"month":2,"riseRate":0.333333,"avgChangeRate":0.081442},{"month":3,"riseRate":0.25,"avgChangeRate":0.095856},{"month":4,"riseRate":0,"avgChangeRate":-0.078413},{"month":5,"riseRate":1,"avgChangeRate":0.100473},{"month":6,"riseRate":0.25,"avgChangeRate":-0.072669},{"month":7,"riseRate":0.666667,"avgChangeRate":-0.022154},{"month":8,"riseRate":0.666667,"avgChangeRate":0.001437},{"month":9,"riseRate":0.333333,"avgChangeRate":0.388697},{"month":10,"riseRate":0.666667,"avgChangeRate":-0.001589},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.0429},{"month":12,"riseRate":0.333333,"avgChangeRate":0.032291}],"exchange":"NASDAQ","name":"Mineralys Therapeutics, Inc.","nameEN":"Mineralys Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mineralys Therapeutics, Inc.(MLYS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Mineralys Therapeutics, Inc.(MLYS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Mineralys Therapeutics, Inc.,MLYS,Mineralys Therapeutics, Inc.股票,Mineralys Therapeutics, Inc.股票老虎,Mineralys Therapeutics, Inc.股票老虎国际,Mineralys Therapeutics, Inc.行情,Mineralys Therapeutics, Inc.股票行情,Mineralys Therapeutics, Inc.股价,Mineralys Therapeutics, Inc.股市,Mineralys Therapeutics, Inc.股票价格,Mineralys Therapeutics, Inc.股票交易,Mineralys Therapeutics, Inc.股票购买,Mineralys Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mineralys Therapeutics, Inc.(MLYS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Mineralys Therapeutics, Inc.(MLYS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction